|
|
 |
|
Viewing report
|
|
|
|
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 35
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
Summary
Adherex technologies Inc. (Adherex) is engaged in the discovery and development of novel cancer therapeutics. The company focuses on tumor cells and tumor blood vessels and oncology. The products of the company are in preclinical and clinical stage of development. It is focused on Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which the company is developing to improve the tolerability and effectiveness of 5-fluorouracil (5-FU), one of the widely used oncology drugs. Adherex in-licensed eniluracil from GlaxoSmithKline (GSK). Under the terms of the Development and License Agreement, Adherex received an exclusive license for eniluracil for all indications. It is incorporated in Ontario, Canada, and headquartered in North Carolina,US.
Adherex Technologies Inc. Key Recent Developments…
May 13, 2011 Adherex Reports Net Income Of $4.7m For Q1 2011
Mar 31, 2011 Adherex Reports Net Loss Of $7.8m For Q4 2010
Nov 15, 2010 Adherex Reports Net Income Of $1.7 Million For Q3 2010
Aug 13, 2010 Adherex Reports Net Loss Of $0.4 Million For Q2 2010
May 13, 2010 Adherex Reports Net Loss Of $0.4 Million For Q1 2010
This comprehensive SWOT profile of Adherex Technologies Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Adherex Technologies Inc. - Product Pipeline Review - H2 2011
Adherex Technologies Inc. - Product Pipeline Review - Q1 2011
Adherex Technologies Inc. - Product Pipeline Review - Q4 2010
Adherex Technologies Inc. - Product Pipeline Review - Q4 2010
Thallion Pharmaceuticals Inc. (TLN) - Financial and Strategic SWOT Analysis Review
Halozyme Therapeutics, Inc. (HALO) - Financial and Strategic SWOT Analysis Review
Exelixis, Inc. (EXEL) - Financial and Strategic SWOT Analysis Review
Icagen Inc (ICGN) - Financial and Strategic SWOT Analysis Review
Progenics Pharmaceuticals, Inc. (PGNX) - Financial and Strategic SWOT Analysis Review
ArQule, Inc. (ARQL) - Financial and Strategic SWOT Analysis Review
|
|
|
|
